LPL Financial LLC Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA)

LPL Financial LLC purchased a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,167 shares of the company’s stock, valued at approximately $199,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PRVA. Park Avenue Securities LLC increased its stake in Privia Health Group by 3.8% during the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after buying an additional 532 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after purchasing an additional 533 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. HighTower Advisors LLC raised its stake in Privia Health Group by 5.0% in the 4th quarter. HighTower Advisors LLC now owns 19,469 shares of the company’s stock valued at $381,000 after purchasing an additional 932 shares during the last quarter. Finally, US Bancorp DE lifted its holdings in Privia Health Group by 6.7% in the 4th quarter. US Bancorp DE now owns 18,058 shares of the company’s stock valued at $353,000 after purchasing an additional 1,134 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on PRVA shares. Stephens reaffirmed an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Piper Sandler raised their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, February 28th. Needham & Company LLC restated a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. Finally, Barclays lifted their price objective on Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 10th. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $27.14.

Privia Health Group Trading Up 0.9 %

NASDAQ PRVA opened at $23.41 on Wednesday. The stock has a market cap of $2.84 billion, a PE ratio of 234.12, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The stock has a fifty day simple moving average of $23.57 and a 200-day simple moving average of $21.98.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the sale, the chief financial officer now directly owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 10.70% of the stock is currently owned by insiders.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.